Q9UHB7 (AFF4_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 29, 2013.
Version 95.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: AF4/FMR2 family member 4 Alternative name(s): ALL1-fused gene from chromosome 5q31 protein Short name=Protein AF-5q31 Major CDK9 elongation factor-associated protein | ||||||
| Gene names |
| ||||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||||
| Taxonomic identifier | 9606 [NCBI] | ||||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 1163 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Key component of the super elongation complex (SEC), a complex required to increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNA. In the SEC complex, AFF4 acts as a central scaffold that recruits other factors through direct interactions with ELL proteins (ELL, ELL2 or ELL3) and the P-TEFb complex. In case of infection by HIV-1 virus, the SEC complex is recruited by the viral Tat protein to stimulate viral gene expression. Ref.16 Ref.17 Ref.23 |
| Subunit structure | Interacts with ELL3; the interaction is direct By similarity. Interacts with ELL2; the interaction is direct and leads to stabilize ELL2 and prevent ELL2 ubiquitination and degradation. Component of the super elongation complex (SEC), at least composed of EAF1, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb complex and ELL (ELL, ELL2 or ELL3). Interacts with ELL. Ref.2 Ref.16 Ref.17 Ref.21 |
| Subcellular location | |
| Tissue specificity | Ubiquitously expressed. Strongly expressed in heart, placenta, skeletal muscle, pancreas and to a lower extent in brain. Ref.1 Ref.2 |
| Developmental stage | Expressed in fetal heart, lung, brain and to a lower extent liver. Ref.1 |
| Involvement in disease | A chromosomal aberration involving AFF4 is found in acute lymphoblastic leukemia (ALL). Insertion ins(5;11)(q31;q13q23) that forms a MLL-AFF4 fusion protein. |
| Sequence similarities | Belongs to the AF4 family. |
| Sequence caution | The sequence AAI00288.1 differs from that shown. Reason: Contaminating sequence. Potential poly-A sequence. The sequence BAD92784.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Transcription Transcription regulation |
| Cellular component | Nucleus |
| Coding sequence diversity | Alternative splicing Chromosomal rearrangement Polymorphism |
| Disease | Proto-oncogene |
| PTM | Phosphoprotein |
| Technical term | 3D-structure Complete proteome Direct protein sequencing Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | spermatid development Inferred from electronic annotation. Source: Compara transcription from RNA polymerase II promoterTraceable author statement Ref.1. Source: ProtInc |
| Cellular_component | mitochondrion Inferred from direct assay. Source: HPA nucleolusInferred from direct assay. Source: HPA |
| Molecular_function | sequence-specific DNA binding transcription factor activity Traceable author statement Ref.1. Source: ProtInc |
| Complete GO annotation... | |
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CCNT1 | O60563 | 5 | EBI-395282,EBI-2479671 | |
| MLLT1 | Q03111 | 8 | EBI-395282,EBI-1384215 | |
| MLLT3 | P42568 | 4 | EBI-395282,EBI-716132 | |
| tat | P04608 | 4 | EBI-395282,EBI-6164389 | From a different organism. |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q9UHB7-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q9UHB7-2) The sequence of this isoform differs from the canonical sequence as follows: 880-900: EKAPSSSSNCPPSAPTLDSSK → VKCWGPGAFENHSTCHVTFPG 901-1163: Missing. | ||||||
| Isoform 3 (identifier: Q9UHB7-3) The sequence of this isoform differs from the canonical sequence as follows: 351-353: ESQ → VSK 354-1163: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||
Molecule processing | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 1163 | 1163 | AF4/FMR2 family member 4 | PRO_0000239393 | ||||||||||
Regions | ||||||||||||||
| Compositional bias | 102 – 461 | 360 | Ser-rich | |||||||||||
| Compositional bias | 836 – 899 | 64 | Ser-rich | |||||||||||
Sites | ||||||||||||||
| Site | 350 – 351 | 2 | Breakpoint for insertion to form MLL-AFF4 fusion protein | |||||||||||
Amino acid modifications | ||||||||||||||
| Modified residue | 387 | 1 | Phosphoserine Ref.13 | |||||||||||
| Modified residue | 388 | 1 | Phosphoserine Ref.13 | |||||||||||
| Modified residue | 389 | 1 | Phosphoserine Ref.13 | |||||||||||
| Modified residue | 392 | 1 | Phosphoserine Ref.13 | |||||||||||
| Modified residue | 549 | 1 | Phosphoserine Ref.12 Ref.14 | |||||||||||
| Modified residue | 671 | 1 | Phosphoserine Ref.13 Ref.14 | |||||||||||
| Modified residue | 674 | 1 | Phosphothreonine Ref.11 | |||||||||||
| Modified residue | 694 | 1 | Phosphoserine Ref.13 | |||||||||||
| Modified residue | 703 | 1 | Phosphoserine Ref.8 Ref.13 | |||||||||||
| Modified residue | 706 | 1 | Phosphoserine Ref.8 Ref.13 | |||||||||||
| Modified residue | 712 | 1 | Phosphotyrosine Ref.13 | |||||||||||
| Modified residue | 814 | 1 | Phosphoserine Ref.12 Ref.18 | |||||||||||
| Modified residue | 836 | 1 | Phosphoserine Ref.18 | |||||||||||
| Modified residue | 1043 | 1 | Phosphoserine Ref.12 Ref.13 Ref.14 Ref.18 | |||||||||||
| Modified residue | 1055 | 1 | Phosphoserine Ref.12 Ref.13 | |||||||||||
| Modified residue | 1058 | 1 | Phosphoserine Ref.13 Ref.14 Ref.15 | |||||||||||
| Modified residue | 1062 | 1 | Phosphoserine Ref.13 | |||||||||||
Natural variations | ||||||||||||||
| Alternative sequence | 351 – 353 | 3 | ESQ → VSK in isoform 3. | VSP_019218 | ||||||||||
| Alternative sequence | 354 – 1163 | 810 | Missing in isoform 3. | VSP_019219 | ||||||||||
| Alternative sequence | 880 – 900 | 21 | EKAPS…LDSSK → VKCWGPGAFENHSTCHVTFP G in isoform 2. | VSP_019220 | ||||||||||
| Alternative sequence | 901 – 1163 | 263 | Missing in isoform 2. | VSP_019221 | ||||||||||
| Natural variant | 136 | 1 | T → P. Corresponds to variant rs34527550 [ dbSNP | Ensembl ]. | VAR_053003 | ||||||||||
| Natural variant | 757 | 1 | S → T Found in a clear cell renal carcinoma case; somatic mutation. Ref.24 | VAR_064693 | ||||||||||
Experimental info | ||||||||||||||
| Sequence conflict | 264 | 1 | E → G in AAM00184. Ref.2 | |||||||||||
| Sequence conflict | 359 | 1 | T → I in AAM00184. Ref.2 | |||||||||||
| Sequence conflict | 383 | 1 | D → G in AAM00184. Ref.2 | |||||||||||
| Sequence conflict | 445 | 1 | E → G in AAM00184. Ref.2 | |||||||||||
| Sequence conflict | 870 | 1 | K → R in AAF28915. Ref.7 | |||||||||||
Secondary structure | ||||||||||||||
Helix Strand Turn | ||||||||||||||
| Helix | 47 – 55 | 9 | ||||||||||||
| Helix | 59 – 62 | 4 | ||||||||||||
| Helix | 63 – 65 | 3 | ||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "AF5q31, a newly identified AF4-related gene, is fused to MLL in infant acute lymphoblastic leukemia with ins(5;11)(q31;q13q23)." Taki T., Kano H., Taniwaki M., Sako M., Yanagisawa M., Hayashi Y. Proc. Natl. Acad. Sci. U.S.A. 96:14535-14540(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH MLL, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE. Tissue: Placenta. |
| [2] | "MCEF, the newest member of the AF4 family of transcription factors involved in leukemia, is a positive transcription elongation factor-b-associated protein." Estable M.C., Naghavi M.H., Kato H., Xiao H., Qin J., Vahlne A., Roeder R.G. J. Biomed. Sci. 9:234-245(2002) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PROTEIN SEQUENCE OF 111-122, IDENTIFICATION IN P-TEFB COMPLEX, TISSUE SPECIFICITY, SUBCELLULAR LOCATION. Tissue: Fetal brain. |
| [3] | Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F. Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Brain. |
| [4] | "The DNA sequence and comparative analysis of human chromosome 5." Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S., Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M., She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S. Rubin E.M.Nature 431:268-274(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-363 (ISOFORMS 1/2). Tissue: Blood, Brain and Skin. |
| [7] | "Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells." Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G., Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W., Tao J., Huang Q.-H., Zhou J., Hu G.-X. Chen Z.Genome Res. 10:1546-1560(2000) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 788-1163 (ISOFORM 2). Tissue: Umbilical cord blood. |
| [8] | "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-703 AND SER-706, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [9] | "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P. Nat. Biotechnol. 24:1285-1292(2006) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [10] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Embryonic kidney. |
| [11] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-674, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [12] | "Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549; SER-814; SER-1043 AND SER-1055, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [13] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387; SER-388; SER-389; SER-392; SER-671; SER-694; SER-703; SER-706; TYR-712; SER-1043; SER-1055; SER-1058 AND SER-1062, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [14] | "Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-549; SER-671; SER-1043 AND SER-1058, MASS SPECTROMETRY. |
| [15] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1058, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [16] | "HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription." He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J., Alber T., Zhou Q. Mol. Cell 38:428-438(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE SEC COMPLEX. |
| [17] | "AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia." Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L., Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A. Mol. Cell 37:429-437(2010) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, IDENTIFICATION IN THE SEC COMPLEX. |
| [18] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-814; SER-836 AND SER-1043, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [19] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [20] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "The ubiquitin ligase Siah1 controls ELL2 stability and formation of super elongation complexes to modulate gene transcription." Liu M., Hsu J., Chan C., Li Z., Zhou Q. Mol. Cell 46:325-334(2012) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH ELL2. |
| [22] | "The super elongation complex (SEC) family in transcriptional control." Luo Z., Lin C., Shilatifard A. Nat. Rev. Mol. Cell Biol. 13:543-547(2012) [PubMed] [Europe PMC] [Abstract] Cited for: REVIEW ON THE SUPER ELONGATION COMPLEX. |
| [23] | "HIV-1 Tat recruits transcription elongation factors dispersed along a flexible AFF4 scaffold." Chou S., Upton H., Bao K., Schulze-Gahmen U., Samelson A.J., He N., Nowak A., Lu H., Krogan N.J., Zhou Q., Alber T. Proc. Natl. Acad. Sci. U.S.A. 110:E123-E131(2013) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION. |
| [24] | "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma." Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H., Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J., Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M. Futreal P.A.Nature 469:539-542(2011) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT THR-757. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AF197927 mRNA. Translation: AAF18981.1. AF213987 mRNA. Translation: AAM00184.2. AB209547 mRNA. Translation: BAD92784.1. Different initiation. AC004500 Genomic DNA. No translation available. CH471062 Genomic DNA. Translation: EAW62305.1. BC063007 mRNA. Translation: AAH63007.1. BC100287 mRNA. Translation: AAI00288.1. Sequence problems. BC137226 mRNA. Translation: AAI37227.1. AF161355 mRNA. Translation: AAF28915.1. | ||||||||||||
| IPI | IPI00004344. IPI00383219. IPI00658213. | ||||||||||||
| RefSeq | NP_055238.1. NM_014423.3. | ||||||||||||
| UniGene | Hs.519313. Hs.664840. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q9UHB7. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| IntAct | Q9UHB7. 15 interactions. | ||||||||||||
| MINT | MINT-1469196. | ||||||||||||
| STRING | 9606.ENSP00000265343. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q9UHB7. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 74720814. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q9UHB7. | ||||||||||||
| PeptideAtlas | Q9UHB7. | ||||||||||||
| PRIDE | Q9UHB7. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 27125. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000265343; ENSP00000265343; ENSG00000072364. ENST00000378595; ENSP00000367858; ENSG00000072364. | ||||||||||||
| GeneID | 27125. | ||||||||||||
| KEGG | hsa:27125. | ||||||||||||
| UCSC | uc003kyd.3. human. uc003kye.1. human. uc003kyf.4. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 27125. | ||||||||||||
| GeneCards | GC05M132211. | ||||||||||||
| HGNC | HGNC:17869. AFF4. | ||||||||||||
| HPA | HPA023690. | ||||||||||||
| MIM | 604417. gene. | ||||||||||||
| neXtProt | NX_Q9UHB7. | ||||||||||||
| PharmGKB | PA142672641. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | NOG121636. | ||||||||||||
| HOVERGEN | HBG004189. | ||||||||||||
| InParanoid | Q9UHB7. | ||||||||||||
| KO | K15185. | ||||||||||||
| OMA | TEHLKNS. | ||||||||||||
| OrthoDB | EOG4CC40N. | ||||||||||||
| PhylomeDB | Q9UHB7. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q9UHB7. | ||||||||||||
| Bgee | Q9UHB7. | ||||||||||||
| CleanEx | HS_AFF4. | ||||||||||||
| Genevestigator | Q9UHB7. | ||||||||||||
| GermOnline | ENSG00000072364. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR007797. TF_AF4/FMR2. [Graphical view] | ||||||||||||
| PANTHER | PTHR10528. PTHR10528. 1 hit. | ||||||||||||
| Pfam | PF05110. AF-4. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| ChiTaRS | AFF4. human. | ||||||||||||
| GenomeRNAi | 27125. | ||||||||||||
| NextBio | 49830. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | AFF4_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9UHB7 Secondary accession number(s): B2RP19 Q9P0E4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 5 Human chromosome 5: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
